Antonella d'Arminio Monforte mainly investigates Internal medicine, Immunology, Acquired immunodeficiency syndrome, Cohort study and Viral load. Her research on Internal medicine often connects related topics like Surgery. Her studies deal with areas such as Myocardial infarction and Pneumonia as well as Surgery.
Her research integrates issues of Rate ratio and Poisson regression in her study of Immunology. Antonella d'Arminio Monforte combines subjects such as Odds ratio, Epidemiology, Pediatrics and Hazard ratio with her study of Acquired immunodeficiency syndrome. Her study focuses on the intersection of Cohort study and fields such as Mortality rate with connections in the field of Adverse effect, Cause of death and Young adult.
Her primary areas of investigation include Internal medicine, Immunology, Acquired immunodeficiency syndrome, Cohort and Viral load. Her Internal medicine study combines topics in areas such as Gastroenterology and Ritonavir. Her Immunology research focuses on subjects like Virology, which are linked to Hiv infected.
Her research investigates the link between Acquired immunodeficiency syndrome and topics such as Pediatrics that cross with problems in Antiretroviral therapy. Her work deals with themes such as Hepatitis C and Incidence, which intersect with Cohort. Her Cohort study research includes elements of Prospective cohort study, Risk factor and Hazard ratio.
Internal medicine, Cohort, Cohort study, Disease and Viral load are her primary areas of study. Her Internal medicine research incorporates elements of Gastroenterology and Ritonavir. Antonella d'Arminio Monforte has researched Cohort in several fields, including Incidence, Discontinuation, Population study, Acquired immunodeficiency syndrome and Proportional hazards model.
Her Cohort study research is multidisciplinary, incorporating perspectives in Observational study, Seroconversion and Risk factor. Her Viral load study is concerned with the larger field of Immunology. Her Immunology research is multidisciplinary, relying on both Men who have sex with men and Homeostasis.
Antonella d'Arminio Monforte mostly deals with Internal medicine, Cohort, Hazard ratio, Viral load and Immunology. Her studies in Internal medicine integrate themes in fields like Abacavir and Ritonavir. The study incorporates disciplines such as Lower risk, Prospective cohort study, Discontinuation and Cohort study in addition to Cohort.
Her Hazard ratio research incorporates themes from Acquired immunodeficiency syndrome, Retrospective cohort study, Abacavir/Lamivudine, Lamivudine and Survival analysis. Her Viral load study integrates concerns from other disciplines, such as Viremia and Proportional hazards model. In general Immunology, her work in Perforin, CD8 and Acquired immune system is often linked to CXCL9 linking many areas of study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Combination antiretroviral therapy and the risk of myocardial infarction
Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte.
The New England Journal of Medicine (2003)
Class of antiretroviral drugs and the risk of myocardial infarction.
Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber.
The New England Journal of Medicine (2007)
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips.
The Lancet (2002)
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study
Rainer Weber;Caroline A Sabin;Nina Friis-Møller;Peter Reiss.
JAMA Internal Medicine (2006)
Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study
Nina Friis-Møller;Rainer Weber;Peter Reiss;Rodolphe Thiebaut.
AIDS (2003)
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
Caroline Sabin;Signe Westring Worm;Rainer Weber.
The Lancet (2008)
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf.
The Lancet (2009)
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
Colette J Smith;Lene Ryom;Rainer Weber;Philippe Morlat.
The Lancet (2014)
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
Signe Westring Worm;Caroline Sabin;Rainer Weber;Peter Reiss.
The Journal of Infectious Diseases (2010)
Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature.
Adriana Ammassari;Maria Paola Trotta;Rita Murri;Francesco Castelli.
Journal of Acquired Immune Deficiency Syndromes (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Rigshospitalet
University of Amsterdam
University College London
Catholic University of the Sacred Heart
University College London
University College London
University of Zurich
Columbia University
University College London
University of Modena and Reggio Emilia
Qatar Computing Research Institute
Georgetown University
Bank of England
Ghent University
ETH Zurich
University of Bremen
University at Buffalo, State University of New York
Florida Museum of Natural History
University of Calgary
Aarhus University
National Museum of Natural History
Desert Research Institute
Kiel University
Innsbruck Medical University
Griffith University
Carleton University